MUMBAI: Dabur’s Q1 results are proof that nature’s remedies still pack a punch on the balance sheet. The homegrown FMCG major reported a consolidated net profit of Rs 508 crore for the quarter ended 30 June 2025, registering a robust year-on-year jump from Rs 494 crore in Q1 last year and Rs 313 crore in the preceding quarter.
Riding on a wave of resilient demand and smart cost management, Dabur clocked Rs 3,405 crore in consolidated revenue from operations up from Rs 3,349 crore in the same period last year and a sharp rise from Rs 2,830 crore in the March quarter.
The company’s profit before tax stood at Rs 663 crore, up from Rs 642 crore in Q1FY25 and Rs 412 crore in Q4FY25. Total expenses were contained at Rs 2,886 crore for the June quarter. Of this, Rs 1,424 crore went into raw materials, Rs 344 crore into stock-in-trade, and Rs 338 crore into employee benefits.
Advertising and publicity remained a priority with Rs 394 crore spent, even as other operating costs totalled Rs 202 crore. Dabur’s focus on product innovation and brand-building clearly continues at pace.
From a segmental perspective, the Consumer Care division led the pack, raking in Rs 2,705 crore in revenue, followed by the Foods segment at Rs 621 crore. Retail and other businesses brought in Rs 26 crore and Rs 44 crore respectively. Segment profit from Consumer Care alone stood at Rs 644 crore.
On the balance sheet, Dabur reported total consolidated assets of Rs 17,244 crore, with liabilities at Rs 5,493 crore. Debt remained in check, with the debt-to-equity ratio at 0.13 and current ratio at 1.74. Net worth stood at Rs 11,230 crore.
Meanwhile, the company continues to back its global playbook, with subsidiaries ranging from Dabur Egypt and Naturelle LLC to Dermoviva in the US and Namaste Laboratories. The international business continues to be a strategic growth engine.
In terms of shareholder return, Dabur’s basic and diluted earnings per share for Q1 stood at Rs 2.90, a notable jump from Rs 1.81 in Q4FY25.
With the monsoon season known to fuel demand for healthcare and personal care items, Dabur’s green shoots are likely to blossom further in the quarters ahead.
Leave a Reply